Evidence map›Paper›PMID 30971955›Full record

ArticleFrontiers in physiology2019

Gliclazide Prevents 5-FU-Induced Oral Mucositis by Reducing Oxidative Stress, Inflammation, and P-Selectin Adhesion Molecules.

Cristiane Assunção da Costa Cunha Mafra, Roseane Carvalho Vasconcelos, Caroline Addison Carvalho Xavier de Medeiros, Renata Ferreira de Carvalho Leitão, Gerly Anne de Castro Brito, Deiziane Viana da Silva Costa, Gerlane Coelho Bernardo Guerra, Raimundo Fernandes de Araújo, Aldo Cunha Medeiros, Aurigena Antunes de Araújo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Jingzhi Niuhuangjiedu Tablet Ameliorates Oral MucositisCombinatorial chemistry & high throughput screening · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Peripherally Acting Opioids in Orofacial Pain.Frontiers in neuroscience · 2021
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Cristiane Assunção da Costa Cunha MafraPostgraduate Programs in Oral Science, Department of Biophysics and Pharmacology, Federal University of Rio Grande Norte, Natal, Brazil.
Roseane Carvalho VasconcelosPostgraduate Program in Public Health, Department of Biophysics and Pharmacology, UFRN, Natal, Brazil.
Caroline Addison Carvalho Xavier de MedeirosDepartment of Biophysics and Pharmacology, UFRN, Natal, Brazil.
Renata Ferreira de Carvalho LeitãoPostgraduate Programs in Pharmacology and Morphology, Department of Morphology/Pharmacology, Federal University of Ceará, Fortaleza, Brazil.
Gerly Anne de Castro BritoPostgraduate Programs in Pharmacology and Morphology, Department of Morphology/Pharmacology, Federal University of Ceará, Fortaleza, Brazil.
Deiziane Viana da Silva CostaPostgraduate Programs in Pharmacology and Morphology, Department of Morphology/Pharmacology, Federal University of Ceará, Fortaleza, Brazil.
Gerlane Coelho Bernardo GuerraPostgraduate Programs in Postgraduate Program in Biological Science/Pharmaceutical Science, Department of Biophysical and Pharmacology, UFRN, Natal, Brazil.
Raimundo Fernandes de AraújoPostgraduate Programs in Functional and Structural Biology and Health Science, Department of Morphology, UFRN, Natal, Brazil.
Aldo Cunha MedeirosPostgraduate Programs in Health Science, Department of Surgery, UFRN, Natal, Brazil.
Aurigena Antunes de AraújoPostgraduate Oral Science, Postgraduate Programs in Pharmaceutical Science, Department of Biophysics and Pharmacology, Federal University of Rio Grande Norte, Natal, Brazil.
Universidade Federal do Rio Grande do Norte · BRUniversidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral mucositis (OM) is one of the main side effects of the head and neck cancer treatment, particularly radiotherapy and/or chemotherapy. OM is characterized by ulcers, erythema, dysphagia, xerostomia, and increased susceptibility to opportunistic infections. In the perspective of finding pharmacological therapies to prevent inflammation and ulceration of OM, the investigation of the pleiotropic effect of commercial drugs is needed, among them gliclazide, an antidiabetic drug. This study aimed to evaluate the effect of gliclazide in an experimental OM model induced by 5-fluorouracil. Male hamsters were pre-treated with oral gliclazide (1, 5, or 10 mg/kg) for 10 days. Cheek pouch samples were subjected to histopathological and immunohistochemical analysis (COX

Indexed as

5-fluorouracilgliclazideinflammationoral mucositisoxidative stress

Identifiers

PMID30971955
PMCPMC6445135
OpenAlexW2924562010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.